Groupleader, Associate Professor
Department of Health Technology
Building 423 Room 108
2800 Kgs. Lyngby
Nanostructures and materials properties Nanomedicines Nanomaterials
Andrew Urquhart's expertise sits within nanomedicines, pharmaceutics and the physical chemistry of pharmaceutical materials. He joined the Center of Nanomedicine and Theranostics at DTU in 2014 having previously work at the Strathclyde Institute of Pharmacy and Biomedical Sciences in the UK. The current major research focus of Andrew's group is the development of new nanomedicines for the treatment of neurovascular diseases.